- Home
- URG vs ATAI Comparison
URG vs ATAI Comparison
Compare URG & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- ATAI
- Stock Information
- Founded
- URG 2004
- ATAI 2018
- Country
- URG United States
- ATAI Germany
- Employees
- URG N/A
- ATAI N/A
- Industry
- URG Precious Metals
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- URG Basic Materials
- ATAI Health Care
- Exchange
- URG Nasdaq
- ATAI Nasdaq
- Market Cap
- URG 419.5M
- ATAI 444.7M
- IPO Year
- URG N/A
- ATAI 2021
- Fundamental
- Price
- URG $1.18
- ATAI $3.88
- Analyst Decision
- URG Strong Buy
- ATAI Strong Buy
- Analyst Count
- URG 3
- ATAI 3
- Target Price
- URG $2.63
- ATAI $13.33
- AVG Volume (30 Days)
- URG 4.0M
- ATAI 7.1M
- Earning Date
- URG 08-05-2025
- ATAI 08-14-2025
- Dividend Yield
- URG N/A
- ATAI N/A
- EPS Growth
- URG N/A
- ATAI N/A
- EPS
- URG N/A
- ATAI N/A
- Revenue
- URG $39,488,000.00
- ATAI $2,309,000.00
- Revenue This Year
- URG N/A
- ATAI $423.05
- Revenue Next Year
- URG $224.22
- ATAI N/A
- P/E Ratio
- URG N/A
- ATAI N/A
- Revenue Growth
- URG 149.20
- ATAI 510.85
- 52 Week Low
- URG $0.55
- ATAI $1.03
- 52 Week High
- URG $1.42
- ATAI $4.40
- Technical
- Relative Strength Index (RSI)
- URG 45.88
- ATAI 57.64
- Support Level
- URG $1.15
- ATAI $3.87
- Resistance Level
- URG $1.29
- ATAI $4.27
- Average True Range (ATR)
- URG 0.07
- ATAI 0.34
- MACD
- URG -0.02
- ATAI -0.05
- Stochastic Oscillator
- URG 17.86
- ATAI 53.98
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.